Myocardial InfarctionPercutaneous Coronary InterventionAngioplasty, Balloon, CoronaryMyocardial ReperfusionElectrocardiographyTime-to-TreatmentTransportation of PatientsPatient TransferTreatment OutcomeTime FactorsEmergency Medical ServicesFibrinolytic AgentsThrombolytic TherapyCoronary ThrombosisPlatelet Aggregation InhibitorsCoronary AngiographyCoronary OcclusionThrombectomyEnoxaparinHospital MortalitySuctionPlatelet Glycoprotein GPIIb-IIIa ComplexAcute Coronary SyndromeImmunoglobulin Fab FragmentsRegistriesTiclopidineDrug-Eluting StentsShock, CardiogenicStentsProspective StudiesRecurrenceMyocardial RevascularizationKaplan-Meier EstimateHemorrhageChi-Square DistributionAnticoagulantsRisk AssessmentRisk FactorsRetrospective StudiesPredictive Value of TestsHeparinFollow-Up StudiesRandomized Controlled Trials as TopicCoronary CirculationProportional Hazards ModelsBiological MarkersLogistic ModelsPrognosisNo-Reflow PhenomenonCardiology Service, HospitalAmbulancesRegional Medical ProgramsRegional Health PlanningCardiovascular AgentsMetalsCreatine Kinase, MB FormHospital Communication SystemsCoronary Care UnitsMagnetic Resonance Imaging, CineHospitals, CommunityPropensity ScoreEmergency Medical TechniciansStroke VolumeVentricular Function, LeftTriageAspirinRadial ArteryMicrocirculationIschemic PostconditioningAmerican Heart AssociationPractice Guidelines as TopicHirudinsCoronary Artery DiseaseAngina, UnstableSirolimusAir AmbulancesROC CurveAngioplastyHospitalizationEmergency TreatmentGuideline AdherenceEmbolismCoronary VesselsAcute DiseaseOdds RatioTroponin IContrast MediaOutcome and Process Assessment (Health Care)ThrombosisCardiologyAntithrombinsAngina, StableSingle-Chain AntibodiesMultivariate AnalysisPlaque, AtheroscleroticC-Reactive ProteinFranceParisSeverity of Illness IndexVermont